Brain Stem Glioma

12 clinical trials · Condition

Record	Firm	Date
Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (NCT03396575)	University of Florida	2018-07-17
Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22 (NCT01884740)	Weill Medical College of Cornell University	2013-06-01
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas (NCT01514201)	National Cancer Institute (NCI)	2012-02-01
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma (NCT01236560)	National Cancer Institute (NCI)	2011-01-26
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 (NCT01082926)	City of Hope Medical Center	2010-05-01
Methionine PET/CT Studies In Patients With Cancer (NCT00840047)	St. Jude Children's Research Hospital	2009-07-20
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma (NCT01095094)	Case Comprehensive Cancer Center	2009-01-01
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma (NCT00576641)	Cedars-Sinai Medical Center	2007-05-01
Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma (NCT00418327)	Gustave Roussy, Cancer Campus, Grand Paris	2005-06-01

Track Brain Stem Glioma automatically

Every clearance here is in the API, with alerts when new ones post.